Market Place
Sourcing Support
All News #Library
Biotech
Boston Pharma to Present Positive Phase 2 Data on BOS-580 in MASH
15 Nov 2024 //
BUSINESSWIRE
Boston Pharma To Present Phase 2 Results At AASLD Liver Meeting®
16 Oct 2024 //
BUSINESSWIRE
Boston Pharma: FGF21 Analogue BOS-580 Lipid Effects In MASH At EASL
05 Jun 2024 //
BUSINESSWIRE
Boston Presents Data Demonstrating Low Immunogenicity With BOS-580
05 Jan 2024 //
BUSINESSWIRE
Boston Pharmaceuticals Announces Positive Phase 2a Data Supporting BOS-580
10 Nov 2023 //
BUSINESSWIRE
Boston Pharmaceuticals To Present New Phase 2a Data From Investigational BOS-580
07 Nov 2023 //
BUSINESSWIRE
Boston Announces +ve Phase 2a Results from Monthly and Bi-weekly Dosing
21 Jun 2023 //
BUSINESSWIRE
Boston Pharmaceuticals Announces Acceptance of Data from BOS-580 NASH Program
18 May 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.